Literature DB >> 24448244

Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.

Rachelle E Stopczynski1, Daniel P Normolle, Douglas J Hartman, Haoqiang Ying, Jennifer J DeBerry, Klaus Bielefeldt, Andrew D Rhim, Ronald A DePinho, Kathryn M Albers, Brian M Davis.   

Abstract

Perineural tumor invasion of intrapancreatic nerves, neurogenic inflammation, and tumor metastases along extrapancreatic nerves are key features of pancreatic malignancies. Animal studies show that chronic pancreatic inflammation produces hypertrophy and hypersensitivity of pancreatic afferents and that sensory fibers may themselves drive inflammation via neurogenic mechanisms. Although genetic mutations are required for cancer development, inflammation has been shown to be a precipitating event that can accelerate the transition of precancerous lesions to cancer. These observations led us to hypothesize that inflammation that accompanies early phases of pancreatic ductal adenocarcinoma (PDAC) would produce pathologic changes in pancreatic neurons and innervation. Using a lineage-labeled genetically engineered mouse model of PDAC, we found that pancreatic neurotrophic factor mRNA expression and sensory innervation increased dramatically when only pancreatic intraepithelial neoplasia were apparent. These changes correlated with pain-related decreases in exploratory behavior and increased expression of nociceptive genes in sensory ganglia. At later stages, cells of pancreatic origin could be found in the celiac and sensory ganglia along with metastases to the spinal cord. These results demonstrate that the nervous system participates in all stages of PDAC, including those that precede the appearance of cancer. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448244      PMCID: PMC4036226          DOI: 10.1158/0008-5472.CAN-13-2050

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.

Authors:  David A Tuveson; Alice T Shaw; Nicholas A Willis; Daniel P Silver; Erica L Jackson; Sandy Chang; Kim L Mercer; Rebecca Grochow; Hanno Hock; Denise Crowley; Sunil R Hingorani; Tal Zaks; Catrina King; Michael A Jacobetz; Lifu Wang; Roderick T Bronson; Stuart H Orkin; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

2.  Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells.

Authors:  Güralp O Ceyhan; Ihsan Ekin Demir; Burak Altintas; Ulrich Rauch; Gerald Thiel; Michael W Müller; Nathalia A Giese; Helmut Friess; Karl-Herbert Schäfer
Journal:  Biochem Biophys Res Commun       Date:  2008-07-18       Impact factor: 3.575

3.  The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis.

Authors:  Güralp O Ceyhan; Frank Bergmann; Mustafa Kadihasanoglu; Mert Erkan; Weon Park; Ulf Hinz; Thomas Giese; Michael W Müller; Markus W Büchler; Nathalia A Giese; Helmut Friess
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 4.  Pancreatic pain.

Authors:  Güralp O Ceyhan; Christoph W Michalski; Ihsan E Demir; Michael W Müller; Helmut Friess
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

5.  TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis.

Authors:  Erica S Schwartz; Jun-Ho La; Nicole N Scheff; Brian M Davis; Kathryn M Albers; G F Gebhart
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

6.  Distribution and neurochemical identification of pancreatic afferents in the mouse.

Authors:  Kenneth E Fasanella; Julie A Christianson; R Savanh Chanthaphavong; Brian M Davis
Journal:  J Comp Neurol       Date:  2008-07-01       Impact factor: 3.215

7.  Pharmacologic disruption of TRPV1-expressing primary sensory neurons but not genetic deletion of TRPV1 protects mice against pancreatitis.

Authors:  Joelle M J Romac; Shannon J McCall; John E Humphrey; Jinseok Heo; Rodger A Liddle
Journal:  Pancreas       Date:  2008-05       Impact factor: 3.327

8.  The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer.

Authors:  Q Zeng; Y Cheng; Q Zhu; Z Yu; X Wu; K Huang; M Zhou; S Han; Q Zhang
Journal:  J Int Med Res       Date:  2008 Jul-Aug       Impact factor: 1.671

9.  Autonomic nerve development contributes to prostate cancer progression.

Authors:  Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

10.  Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact.

Authors:  Shuichi Mitsunaga; Takahiro Hasebe; Taira Kinoshita; Masaru Konishi; Shinichiro Takahashi; Naoto Gotohda; Toshio Nakagohri; Atsushi Ochiai
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

View more
  59 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 2.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

3.  An In Vivo Murine Sciatic Nerve Model of Perineural Invasion.

Authors:  Sylvie Deborde; Yasong Yu; Andrea Marcadis; Chun-Hao Chen; Ning Fan; Richard L Bakst; Richard J Wong
Journal:  J Vis Exp       Date:  2018-04-23       Impact factor: 1.355

Review 4.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

5.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Dongjun Li; Douglas J Hartman; Howard C Crawford; Emily A Muha; Andrew D Rhim; Brian M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 6.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

7.  Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma.

Authors:  Meng Lu; Chun-Hui Yuan; Ling-Fu Zhang; Lian-Yuan Tao; Ying Peng; Li-Mei Guo; Gang Li; Dian-Rong Xiu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

Review 8.  Neural plasticity in pancreatitis and pancreatic cancer.

Authors:  Ihsan Ekin Demir; Helmut Friess; Güralp O Ceyhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

Review 9.  Wrapped to Adapt: Experience-Dependent Myelination.

Authors:  Christopher W Mount; Michelle Monje
Journal:  Neuron       Date:  2017-08-16       Impact factor: 17.173

10.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.